IntrinsicIntrinsic

ATLANTIC AMERICAN CORP

AAME
๐Ÿข Life Insurance

Business Operations Summary

Atlantic American Corporation is a holding company that operates through its subsidiaries in well-defined specialty markets within the life and health and property and casualty insurance industries . The property and casualty operations are conducted through American Southern Insurance Company and American Safety Insurance Company, together known as American Southern, while the life and health operations are conducted through Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company, together known as Bankers Fidelity . Each of American Southern and Bankers Fidelity is managed separately based upon the type of products it offers and is evaluated on its individual performance . The Company's strategy is to focus on well-defined geographic, demographic and/or product niches within the insurance marketplace, with each operating company operating with relative autonomy designed to allow for quick reaction to market opportunities . The Parent has no significant business operations of its own and relies on fees, dividends and other distributions from its operating subsidiaries as the principal source of cash flow to meet its obligations .

The property and casualty insurance business in which American Southern engages is highly competitive, with the principal areas of competition being pricing and service . Many competing property and casualty companies have been in business longer than American Southern, offer more diversified lines of insurance and have substantially greater financial resources . American Southern is licensed to do business in 32 states and the District of Columbia . The life and health insurance business remains highly competitive and includes a large number of insurance companies, many of which are new entrants to the business of providing Medicare Supplement and other accident and health insurance products . Bankers Fidelity has established itself as a trusted carrier of choice for its customers providing quality and sustainability for over 65 years . In order to compete, Bankers Fidelity actively seeks opportunities in niche markets, developing long-term relationships with a select number of independent marketing organizations . Competition for insurance products is based on many factors including premiums charged, terms and conditions of coverage, customer service, financial ratings assigned by independent rating agencies, claims handling, consumer recognition and reputation, perceived financial strength and the experience of the organization in the line of business being written .

The Company generates revenue primarily from the collection of premiums, as well as from investment income . American Southern provides tailored commercial automobile insurance coverage, on a multi-year contract basis, to state governments, local municipalities and other large motor pools and fleets, known as block accounts, that can be specifically rated and underwritten . The size of the block accounts insured by American Southern are generally such that individual class experience can be determined, which allows for customized policy terms and rates . Bankers Fidelity acquires its clientele through three distribution channels spread across 46 different states and two business divisions, all of which utilize commissioned, independent agents . The three distribution channels include traditional independent agents, brokers who are typically interested in a specific product of Bankers Fidelity and brokers who focus on sales within the group/employer benefits division, Atlantic American Employee Benefits, all of which are responsible for their own marketing and sales activities . Contracting as independent agents enables Bankers Fidelity to effectively expand or contract its sales force without incurring significant expense . Bankers Fidelity had approximately 6,565 licensed agents contracted in both the individual and group divisions as of December 31, 2025 . During 2025, approximately 3,094 of these licensed agents wrote policies on behalf of Bankers Fidelity .

American Southern's primary product lines include commercial automobile insurance, which provides bodily injury and/or property damage liability coverage, uninsured motorist coverage and physical damage coverage for commercial accounts; general liability insurance, which covers bodily injury and/or property damage liability for both premises and completed operations exposures for general classes of business; surety bonds, which are contracts under which the insurance company guarantees to a third party that the primary party will fulfill an obligation in accordance with a contractual agreement; and inland marine policies, which provide motor truck cargo coverage for commercial accounts . American Southern directly provides surety bond coverage for subdivision construction, school bus contracts, as well as performance and payment bonds . For the year ended December 31, 2025, American Southern's net earned premiums were $49,640 thousand from automobile liability, $16,515 thousand from automobile physical damage, $6,121 thousand from general liability, $5,178 thousand from surety, and $7,050 thousand from inland marine, for total net earned premiums of $84,504 thousand .

Bankers Fidelity offers a variety of life and supplemental health products, including ordinary life insurance, Medicare Supplement and other accident and health insurance products . Life Insurance products include non-participating, individual and group whole life insurance policies with a variety of riders and options . Medicare Supplement Insurance includes 8 of the 10 standardized Medicare Supplement plans that were developed in response to the requirements of the Omnibus Budget Reconciliation Act of 1990 . These policies provide insurance coverage for certain expenses not covered by the Medicare program, including but not limited to, copayments and deductibles . Other Accident and Health Insurance coverages include several individual and group policies providing for the payment of benefits that help defray the health care and other costs associated with the treatment of cancer and other critical illnesses . In addition, Bankers Fidelity offers policies that reimburse the costs associated with short-term nursing facility care, policies that provide monthly benefits in the event of a covered disability, and policies that provide cash benefits in the event of a covered accident or a covered hospital stay . Health insurance products, primarily Medicare Supplement insurance, accounted for 84% of Bankers Fidelity's net earned premiums in 2025 while life insurance, including both whole and term life insurance policies, accounted for the balance . In terms of the number of policies written in 2025, 83% were health insurance policies and 17% were life insurance policies . For the year ended December 31, 2025, Bankers Fidelity's net earned premiums were $12,559 thousand from group life, $5,600 thousand from individual life, $75,360 thousand from Medicare Supplement, $9,178 thousand from group accident and health, and $8,941 thousand from other individual health, for total net earned premiums of $111,638 thousand .

During 2025, the Company adopted Accounting Standards Update No. 2018-12, Financial Servicesโ€”Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, as subsequently amended, applying LDTI using the modified retrospective transition method as of January 1, 2024 to its whole life, Medicare Supplement and certain guaranteed-renewable accident and health insurance products . In connection with the preparation of the Company's consolidated financial statements for the year ended December 31, 2025, management identified errors relating to the recognition of due-premium receivables and related premium revenue within the Company's group whole life and group accident and health business, and the Company revised the 2024 financial information presented to reflect the correction of the errors in the appropriate prior periods . The revisions principally resulted in a $5.580 million reduction in insurance premiums and other receivables, a $1.172 million increase in deferred income taxes, net, a $2.923 million reduction in accounts payable and accrued expenses, a $1.485 million reduction in retained earnings, a $0.351 million reduction in 2024 insurance premiums, net and income (loss) before income taxes, and a $0.277 million increase in 2024 net loss . The Company also received notices from The Nasdaq Stock Market LLC stating that because the Company had not yet filed certain delinquent reports, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), and Nasdaq granted an extension until October 12, 2026 to regain compliance . The Company expects that it will receive a staff delisting determination from Nasdaq due to its inability to file each of the delinquent reports by such date .

On a consolidated basis, the Company had net income of $6.0 million, or $0.28 per diluted share, in 2025, compared to net loss of $1.4 million, or $(0.09) per diluted share, in 2024 . Total revenue was $210.4 million in 2025 as compared to $188.41 million in 2024 . Premium revenue increased to $196.1 million in 2025 from $178.6 million in 2024 . Operating income was $3.7 million in 2025 as compared to operating loss of $1.3 million in 2024 . The increase in net income was primarily due to an increase in net earned premiums in the property and casualty operations due to a rate increase upon renewal of a program within the automobile liability line of business, as well as increases in earned premiums in the inland marine cargo and automobile physical damage lines of business that were due to increased premium writings . Also contributing to the increase in net income was the Company's recognition of net unrealized gains on equity securities of $4.5 million and net unrealized losses of $1.5 million during the years ended December 2025 and 2024, respectively . Another contributing factor to the increase in net income was an increase in the net earned premiums for the Medicare Supplement line of business due to new sales within the life and health operations .

Business Outlook & Future Growth Drivers

The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed . The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from financial institutions, will enable the Company to meet its liquidity requirements for the next 12 months and thereafter for the foreseeable future . Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse effect on the Company's liquidity, capital resources or operations .

Bankers Fidelity's marketing and distribution strategy revolves around five pillars: Diversification, Differentiation, Quality, Retention and Profitability . Through unique product offerings such as the Vantage Flex Plusยฎ, a hospital indemnity plan, and Vantage Recoveryยฎ, a short-term care product and a group whole life product featuring a chronic illness rider, the Company is able to offer its distributors an array of products to sell that stand out from the competition . As the Company continues to expand its geographical footprint with agents and products, one of its main objectives is to have a healthy mix of all of its product lines nationwide . Bankers Fidelity is focused on being a niche carrier that delivers superior service, quality products and innovative solutions . Through seasonal campaigns and customer outreach, the Company is focused on client retention and servicing its policyholders through all stages in their lives . In an effort to be sustainable in the marketplace as a long-term partner, senior management is focused on diversification, differentiation, quality and retention to achieve profitability .

American Southern's agent selection process is actively managed by internal marketing personnel with oversight from management, and senior management carefully reviews all new programs prior to acceptance . Most of American Southern's agents are paid an up-front commission with the potential for additional commissions by participating in a profit sharing arrangement that is directly linked to the profitability of the underlying business . American Southern also solicits business from governmental entities and, as an experienced writer of insurance policies for certain governmental programs, the company actively pursues this market on a direct basis . Much of this business is priced by means of competitive bid situations, and as a result, there can be no assurance with respect to the ultimate profitability or ability of the Company to obtain or retain such business at the time of a specific contract renewal . American Southern specializes in underwriting various risks that are sufficiently large enough to establish separate class experience, relying upon the underwriting expertise of its agents . During the course of the policy life, extensive use is made of risk management representatives to assist commercial underwriters in identifying and correcting potential loss exposures and to physically inspect new accounts . The underwriting results from each insured are reviewed on an individual basis periodically, and if results are below expectations, management takes corrective action, which may include adjusting rates, revising underwriting standards, adjusting commissions paid to agents, and/or altering or declining to renew accounts at expiration .

The Company's primary cash needs are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements . Current and expected patterns of claim frequency and severity may change from period to period, but generally are expected to continue within historical ranges . The Company's primary sources of cash are written premiums, investment income and proceeds from the sale and maturity of its invested assets, as well as borrowings from time to time under our revolving credit facility . Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments from the subsidiaries . The principal cash needs of the Parent are for the payment of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company's board of directors from time to time .

The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures . The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of 3-month CME Term SOFR plus applicable tenor spread of 0.26161% plus an applicable margin . The margin ranges from 4.00% to 4.10% . At December 31, 2025, the effective interest rate was 8.13% . The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from existing or potential future financing arrangements . At December 31, 2025, the Company had 55,000 shares of Series D preferred stock outstanding, all of which are held by an affiliate of the Company's controlling shareholder . The outstanding shares of Series D Preferred Stock have a redemption value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company's common stock at the option of the board of directors of the Company) and are cumulative . In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company's common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company's option . The Series D Preferred Stock is not currently convertible . The Company had accrued, but unpaid, dividends on the Series D Preferred Stock of $17.7 thousand at December 31, 2025 and 2024 . During each of 2025 and 2024, the Company paid Series D Preferred Stock dividends of $0.4 million .

Bankers Fidelity Life Insurance Company is a member of the Federal Home Loan Bank of Atlanta, for the primary purpose of enhancing financial flexibility . As a member, BFLIC can obtain access to low-cost funding and also receive dividends on FHLB stock . The membership arrangement provides for credit availability of fifteen percent of statutory admitted assets, or approximately $27.3 million, as of December 31, 2025 . Additional FHLB stock purchases may be required based upon the amount of funds borrowed from the FHLB . As of December 31, 2025, BFLIC has pledged bonds having an amortized cost of $8.9 million to the FHLB . BFLIC may be required to post additional acceptable forms of collateral for any borrowings that it makes in the future from the FHLB . As of December 31, 2025, BFLIC does not have any outstanding borrowings from the FHLB .

On May 12, 2021, the Company entered into a revolving credit agreement with Truist Bank as the lender . The Revolving Credit Agreement provides for an unsecured $10.0 million revolving credit facility that originally matured on April 12, 2024 . On March 22, 2024, the Company entered into a First Amendment to its Revolving Credit Agreement with the Lender . The Amendment, among other things, (a) updates the interest rate provisions to memorialize that the Company pays interest on the unpaid principal balance of outstanding revolving loans at the Adjusted Term SOFR rate, plus 2.00%, (b) extends the maturity date of the revolving credit facility to March 22, 2027, (c) requires the monthly payment of an unused commitment fee of 0.2% of the unused facility amount, and (d) requires that the Company maintain a consolidated net worth of not less than $64.2 million . On May 27, 2026, July 31, 2026, October 9, 2026 and October 15, 2026, the Company and the Lender entered into amendments to the Credit Agreement, each of which had the effect of extending the then-applicable deadlines by which the Company must deliver to the Lender (i) the Company's audited consolidated financial statements for the year ended December 31, 2025, (ii) the Company's interim consolidated financial statements for the quarters ended March 31, 2026, June 30, 2026 and September 30, 2026, and (iii) related certificates of the Company's compliance with financial covenants under the Credit Agreement and certain other matters . The Fifth Amendment to the Revolving Credit Agreement, dated October 15, 2026, also amended the minimum AM Best financial strength rating that must be maintained by American Southern Insurance Company to be no lower than "A-" and waived related defaults under the Credit Agreement occurring prior to such amendment . The Credit Agreement requires the Company to comply with certain covenants, including a debt to capital ratio that restricts the Company from incurring consolidated indebtedness that exceeds 35% of the Company's consolidated capitalization at any time and maintaining a minimum consolidated net worth, as previously mentioned . As of December 31, 2025 and 2024, the Company had outstanding borrowings of $5.0 million and $4.0 million under the Credit Agreement .

The Company's insurance subsidiaries from time-to-time purchase reinsurance from unaffiliated insurers and reinsurers to reduce their potential liability on individual risks and to protect against catastrophic losses . American Southern's basic reinsurance treaties generally cover all claims in excess of specified per occurrence limitations . Limits per occurrence within the reinsurance treaties are as follows: inland marine and automobile physical damage - $225,000 excess of $125,000 retention; and automobile liability and general liability - excess coverage of $2.0 million less retentions that may vary from $100,000 to $700,000 depending on the account . American Southern maintains a property catastrophe treaty with a $5.5 million limit excess of $500,000 retention . Bankers Fidelity has entered into reinsurance contracts ceding the excess of its life retention . The maximum retention by Bankers Fidelity on any one individual life insurance policyholder is $200,000 . As of December 31, 2025, $5.7 million of the $1,040.3 million of life insurance in force at Bankers Fidelity was reinsured under a combination of coinsurance and yearly renewable term agreements . Bankers Fidelity has also entered into a reinsurance contract ceding excess new Medicare Supplement business to General Re Life Corporation . Ceding thresholds are set for all policies issued in a given calendar year . During 2025, the liability of the reinsurer was 71% of all Medicare Supplement business issued by the Company that year . This percentage is calculated based on a cession percentage of 50% on amounts of new business of up to $30 million of annualized premium, and 100% of all new Medicare Supplement business in excess of $30.0 million of annualized premiums . Accordingly, $36.9 million of the Company's $51.9 million of new annualized Medicare Supplement premium was ceded .

Major Risk Factors & Challenges

The Company faces material risks related to its internal control over financial reporting, as management identified deficiencies that constituted a material weakness as of December 31, 2025, and correcting the identified errors addressed the financial-statement effects but did not remediate the material weakness . The Company has received notices from Nasdaq stating that because it had not yet filed certain delinquent reports, it is not in compliance with Nasdaq Listing Rule 5250(c)(1), and the Company expects that it will receive a staff delisting determination from Nasdaq due to its inability to file each of the delinquent reports by the extension date of October 12, 2026 . While the Company intends to appeal such determination to a Nasdaq Hearings Panel, an appeal may not be successful in preventing the suspension of trading, or delisting of, the Company's common stock from Nasdaq . The Company's insurance subsidiaries are subject to regulation and supervision in the jurisdictions in which they do business, and virtually all of the states in which the Company's insurance subsidiaries are licensed to transact business require participation in their respective guaranty funds designed to cover claims against insolvent insurers, with insurers generally subject to assessments of up to 4% of annual direct premiums written in that jurisdiction to pay such claims . As of the date of this Form 10-K, Bankers Fidelity has not yet filed its annual audited statutory financial statements for the fiscal year ended December 31, 2025 or quarterly statutory financial statements for the quarter ended June 30, 2026 with the applicable state insurance regulatory authorities, and if Bankers Fidelity is unable to file the required financial statements by the applicable deadlines, the Company is unable to predict with any certainty what measures may be imposed by the applicable regulatory authorities . The Company's insurance reserves for losses and claims were $113.8 million as of December 31, 2025, and the process of establishing claim reserves requires the use of estimates and judgments, and relatively small changes in estimates of ultimate losses may materially affect the recorded liability and the benefits and losses recognized in the period of revision . The Company's insurance reserves for future policy benefits were $84.7 million as of December 31, 2025, and these reserves are based upon significant management assumptions including mortality, morbidity, policyholder lapses and other termination rates, claim costs, loss ratios, anticipated premium-rate increases, discount rates and expenses .

Management Priorities & Sentiments

Management's message to shareholders emphasizes the Company's focus on well-defined specialty markets within the life and health and property and casualty insurance industries, with each operating company managed separately and evaluated on its individual performance . The Company's strategy is to focus on well-defined geographic, demographic and/or product niches within the insurance marketplace, with each of American Southern and Bankers Fidelity operating with relative autonomy designed to allow for quick reaction to market opportunities . Management's strategic priorities for the period ahead center on diversification, differentiation, quality, retention and profitability, as articulated in Bankers Fidelity's marketing and distribution strategy . Through unique product offerings such as the Vantage Flex Plusยฎ, a hospital indemnity plan, and Vantage Recoveryยฎ, a short-term care product and a group whole life product featuring a chronic illness rider, the Company is able to offer its distributors an array of products to sell that stand out from the competition . As the Company continues to expand its geographical footprint with agents and products, one of its main objectives is to have a healthy mix of all of its product lines nationwide . Management also emphasizes the Company's focus on being a niche carrier that delivers superior service, quality products and innovative solutions, and on client retention through seasonal campaigns and customer outreach . In an effort to be sustainable in the marketplace as a long-term partner, senior management is focused on diversification, differentiation, quality and retention to achieve profitability . The Company believes that its ability to attract and retain highly motivated and skilled employees with diverse backgrounds and experiences is critical to its continued success . The Company and its subsidiaries employed 166 people at December 31, 2025, of which 163 were full-time . Management also notes the Company's ongoing efforts to remediate material weaknesses in internal control over financial reporting and to regain compliance with Nasdaq listing standards .

References

  1. [1] Item 1, Business โ€” The Company
  2. [2] Item 1, Business โ€” The Company
  3. [3] Item 1, Business โ€” The Company
  4. [4] Item 1, Business โ€” The Company
  5. [5] Item 1, Business โ€” The Company
  6. [6] Item 1, Business โ€” Competition
  7. [7] Item 1, Business โ€” Competition
  8. [8] Item 1, Business โ€” Property and Casualty Operations
  9. [9] Item 1, Business โ€” Competition
  10. [10] Item 1, Business โ€” Competition
  11. [11] Item 1, Business โ€” Competition
  12. [12] Item 1, Business โ€” Competition
  13. [13] Item 1, Business โ€” Financial Information by Industry Segment
  14. [14] Item 1, Business โ€” Property and Casualty Operations
  15. [15] Item 1, Business โ€” Property and Casualty Operations
  16. [16] Item 1, Business โ€” Marketing
  17. [17] Item 1, Business โ€” Marketing
  18. [18] Item 1, Business โ€” Marketing
  19. [19] Item 1, Business โ€” Marketing
  20. [20] Item 1, Business โ€” Marketing
  21. [21] Item 1, Business โ€” Property and Casualty Operations
  22. [22] Item 1, Business โ€” Property and Casualty Operations
  23. [23] Item 1, Business โ€” Property and Casualty Operations
  24. [24] Item 1, Business โ€” Life and Health Operations
  25. [25] Item 1, Business โ€” Life and Health Operations
  26. [26] Item 1, Business โ€” Life and Health Operations
  27. [27] Item 1, Business โ€” Life and Health Operations
  28. [28] Item 1, Business โ€” Life and Health Operations
  29. [29] Item 1, Business โ€” Life and Health Operations
  30. [30] Item 1, Business โ€” Life and Health Operations
  31. [31] Item 1, Business โ€” Life and Health Operations
  32. [32] Item 1, Business โ€” Life and Health Operations
  33. [33] Explanatory Note โ€” Adoption of LDTI
  34. [34] Explanatory Note โ€” Revision of Previously Issued Financial Statements
  35. [35] Item 7, MD&A โ€” Revision of Previously Issued Financial Statements
  36. [36] Explanatory Note โ€” Nasdaq Noncompliance
  37. [37] Explanatory Note โ€” Nasdaq Noncompliance
  38. [38] Item 7, MD&A โ€” Overall Corporate Results
  39. [39] Item 7, MD&A โ€” Overall Corporate Results
  40. [40] Item 7, MD&A โ€” Overall Corporate Results
  41. [41] Item 7, MD&A โ€” Overall Corporate Results
  42. [42] Item 7, MD&A โ€” Overall Corporate Results
  43. [43] Item 7, MD&A โ€” Overall Corporate Results
  44. [44] Item 7, MD&A โ€” Overall Corporate Results
  45. [45] Item 7, MD&A โ€” Liquidity and Capital Resources
  46. [46] Item 7, MD&A โ€” Liquidity and Capital Resources
  47. [47] Item 7, MD&A โ€” Liquidity and Capital Resources
  48. [48] Item 1, Business โ€” Marketing
  49. [49] Item 1, Business โ€” Marketing
  50. [50] Item 1, Business โ€” Marketing
  51. [51] Item 1, Business โ€” Marketing
  52. [52] Item 1, Business โ€” Marketing
  53. [53] Item 1, Business โ€” Marketing
  54. [54] Item 1, Business โ€” Marketing
  55. [55] Item 1, Business โ€” Marketing
  56. [56] Item 1, Business โ€” Marketing
  57. [57] Item 1, Business โ€” Marketing
  58. [58] Item 1, Business โ€” Underwriting
  59. [59] Item 1, Business โ€” Underwriting
  60. [60] Item 1, Business โ€” Underwriting
  61. [61] Item 7, MD&A โ€” Liquidity and Capital Resources
  62. [62] Item 7, MD&A โ€” Liquidity and Capital Resources
  63. [63] Item 7, MD&A โ€” Liquidity and Capital Resources
  64. [64] Item 7, MD&A โ€” Liquidity and Capital Resources
  65. [65] Item 7, MD&A โ€” Liquidity and Capital Resources
  66. [66] Item 7, MD&A โ€” Liquidity and Capital Resources
  67. [67] Item 7, MD&A โ€” Liquidity and Capital Resources
  68. [68] Item 7, MD&A โ€” Liquidity and Capital Resources
  69. [69] Item 7, MD&A โ€” Liquidity and Capital Resources
  70. [70] Item 7, MD&A โ€” Liquidity and Capital Resources
  71. [71] Item 7, MD&A โ€” Liquidity and Capital Resources
  72. [72] Item 7, MD&A โ€” Liquidity and Capital Resources
  73. [73] Item 7, MD&A โ€” Liquidity and Capital Resources
  74. [74] Item 7, MD&A โ€” Liquidity and Capital Resources
  75. [75] Item 7, MD&A โ€” Liquidity and Capital Resources
  76. [76] Item 7, MD&A โ€” Liquidity and Capital Resources
  77. [77] Item 7, MD&A โ€” Liquidity and Capital Resources
  78. [78] Item 7, MD&A โ€” Liquidity and Capital Resources
  79. [79] Item 7, MD&A โ€” Liquidity and Capital Resources
  80. [80] Item 7, MD&A โ€” Liquidity and Capital Resources
  81. [81] Item 7, MD&A โ€” Liquidity and Capital Resources
  82. [82] Item 7, MD&A โ€” Liquidity and Capital Resources
  83. [83] Item 7, MD&A โ€” Liquidity and Capital Resources
  84. [84] Item 7, MD&A โ€” Liquidity and Capital Resources
  85. [85] Item 7, MD&A โ€” Liquidity and Capital Resources
  86. [86] Item 7, MD&A โ€” Liquidity and Capital Resources
  87. [87] Item 7, MD&A โ€” Liquidity and Capital Resources
  88. [88] Item 7, MD&A โ€” Liquidity and Capital Resources
  89. [89] Item 7, MD&A โ€” Liquidity and Capital Resources
  90. [90] Item 7, MD&A โ€” Liquidity and Capital Resources
  91. [91] Item 7, MD&A โ€” Liquidity and Capital Resources
  92. [92] Item 1, Business โ€” Reinsurance
  93. [93] Item 1, Business โ€” Reinsurance
  94. [94] Item 1, Business โ€” Reinsurance
  95. [95] Item 1, Business โ€” Reinsurance
  96. [96] Item 1, Business โ€” Reinsurance
  97. [97] Item 1, Business โ€” Reinsurance
  98. [98] Item 1, Business โ€” Reinsurance
  99. [99] Item 1, Business โ€” Reinsurance
  100. [100] Item 1, Business โ€” Reinsurance
  101. [101] Item 1, Business โ€” Reinsurance
  102. [102] Item 1, Business โ€” Reinsurance
  103. [103] Item 1, Business โ€” Reinsurance
  104. [104] Item 7, MD&A โ€” Internal Control Over Financial Reporting
  105. [105] Explanatory Note โ€” Nasdaq Noncompliance
  106. [106] Explanatory Note โ€” Nasdaq Noncompliance
  107. [107] Item 1, Business โ€” Regulation
  108. [108] Item 1, Business โ€” Regulation
  109. [109] Item 7, MD&A โ€” Critical Accounting Estimates
  110. [110] Item 7, MD&A โ€” Critical Accounting Estimates
  111. [111] Item 1, Business โ€” The Company
  112. [112] Item 1, Business โ€” The Company
  113. [113] Item 1, Business โ€” Marketing
  114. [114] Item 1, Business โ€” Marketing
  115. [115] Item 1, Business โ€” Marketing
  116. [116] Item 1, Business โ€” Marketing
  117. [117] Item 1, Business โ€” Marketing
  118. [118] Item 1, Business โ€” Human Capital
  119. [119] Item 1, Business โ€” Human Capital
  120. [120] Explanatory Note โ€” Material Weaknesses in Internal Control over Financial Reporting
  121. [121] Item 7, MD&A โ€” Overall Corporate Results
  122. [122] Item 7, MD&A โ€” Overall Corporate Results
  123. [123] Item 7, MD&A โ€” Overall Corporate Results
  124. [124] Item 7, MD&A โ€” Overall Corporate Results
  125. [125] Item 8, Consolidated Statements of Operations
  126. [126] Item 8, Consolidated Statements of Operations
  127. [127] Item 8, Consolidated Statements of Operations
  128. [128] Item 8, Consolidated Statements of Operations
  129. [129] Item 8, Consolidated Statements of Operations
  130. [130] Item 8, Consolidated Statements of Operations
  131. [131] Item 8, Consolidated Statements of Operations
  132. [132] Item 8, Consolidated Statements of Operations
  133. [133] Item 8, Consolidated Statements of Operations
  134. [134] Item 8, Consolidated Statements of Operations
  135. [135] Item 8, Consolidated Statements of Operations
  136. [136] Item 7, MD&A โ€” Underwriting Results, American Southern
  137. [137] Item 7, MD&A โ€” Underwriting Results, American Southern
  138. [138] Item 7, MD&A โ€” Underwriting Results, American Southern
  139. [139] Item 7, MD&A โ€” Underwriting Results, American Southern
  140. [140] Item 7, MD&A โ€” Underwriting Results, American Southern
  141. [141] Item 7, MD&A โ€” Underwriting Results, American Southern
  142. [142] Item 7, MD&A โ€” Underwriting Results, Bankers Fidelity
  143. [143] Item 7, MD&A โ€” Underwriting Results, Bankers Fidelity
  144. [144] Item 7, MD&A โ€” Underwriting Results, Bankers Fidelity
  145. [145] Item 7, MD&A โ€” Underwriting Results, Bankers Fidelity
  146. [146] Item 7, MD&A โ€” Underwriting Results, Bankers Fidelity
  147. [147] Item 7, MD&A โ€” Underwriting Results, Bankers Fidelity
  148. [148] Item 7, MD&A โ€” Liquidity and Capital Resources
  149. [149] Item 8, Consolidated Balance Sheets
  150. [150] Item 8, Consolidated Balance Sheets
  151. [151] Item 8, Consolidated Balance Sheets
  152. [152] Item 8, Consolidated Balance Sheets
  153. [153] Item 7, MD&A โ€” Liquidity and Capital Resources
  154. [154] Item 7, MD&A โ€” Critical Accounting Estimates
  155. [155] Item 7, MD&A โ€” Critical Accounting Estimates
  156. [156] Item 8, Consolidated Balance Sheets
  157. [157] Item 8, Consolidated Balance Sheets
  158. [158] Item 7, MD&A โ€” Liquidity and Capital Resources
  159. [159] Item 7, MD&A โ€” Liquidity and Capital Resources
  160. [160] Item 7, MD&A โ€” Liquidity and Capital Resources
  161. [161] Item 7, MD&A โ€” Liquidity and Capital Resources
  162. [162] Item 7, MD&A โ€” Liquidity and Capital Resources

Report on Oct 16, 2026